ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 108 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2021. The put-call ratio across all filers is 28.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $21,774 | +15.7% | 26,882 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $18,817 | -0.9% | 26,882 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $18,979 | -53.7% | 26,882 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $41,000 | +51.9% | 26,882 | 0.0% | 0.01% | +100.0% |
Q2 2022 | $27,000 | -30.8% | 26,882 | 0.0% | 0.00% | -25.0% |
Q1 2022 | $39,000 | -72.1% | 26,882 | 0.0% | 0.00% | -73.3% |
Q4 2021 | $140,000 | -10.8% | 26,882 | 0.0% | 0.02% | -21.1% |
Q3 2021 | $157,000 | -27.6% | 26,882 | 0.0% | 0.02% | -26.9% |
Q2 2021 | $217,000 | -3.1% | 26,882 | 0.0% | 0.03% | -13.3% |
Q1 2021 | $224,000 | +9.8% | 26,882 | 0.0% | 0.03% | +3.4% |
Q4 2020 | $204,000 | -28.9% | 26,882 | 0.0% | 0.03% | -37.0% |
Q3 2020 | $287,000 | -29.7% | 26,882 | 0.0% | 0.05% | -35.2% |
Q2 2020 | $408,000 | +82.1% | 26,882 | 0.0% | 0.07% | +47.9% |
Q1 2020 | $224,000 | -50.7% | 26,882 | 0.0% | 0.05% | -36.8% |
Q4 2019 | $454,000 | -21.5% | 26,882 | -13.6% | 0.08% | -29.6% |
Q3 2019 | $578,000 | -8.7% | 31,117 | +12.4% | 0.11% | -16.3% |
Q2 2019 | $633,000 | +9.1% | 27,682 | +0.4% | 0.13% | +30.3% |
Q1 2019 | $580,000 | +100.0% | 27,582 | +9.4% | 0.10% | +65.0% |
Q4 2018 | $290,000 | -53.2% | 25,206 | -6.6% | 0.06% | -42.9% |
Q3 2018 | $620,000 | +13.3% | 26,996 | +10.0% | 0.10% | +6.1% |
Q2 2018 | $547,000 | -2.5% | 24,546 | 0.0% | 0.10% | -3.9% |
Q1 2018 | $561,000 | -12.8% | 24,546 | 0.0% | 0.10% | -12.7% |
Q4 2017 | $643,000 | – | 24,546 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 225,239 | $1,295,123 | 1.10% |
CHARTIST INC /CA/ | 67,073 | $385,667 | 0.23% |